首页 | 本学科首页   官方微博 | 高级检索  
检索        

小剂量顺铂配合放疗治疗食管癌50例
引用本文:陈微,刘文强,宋光辉.小剂量顺铂配合放疗治疗食管癌50例[J].承德医学院学报,2009,26(1).
作者姓名:陈微  刘文强  宋光辉
作者单位:安徽省太和县中医院放疗科,安徽太和,236607
摘    要:目的:探讨超分割放射治疗配合小剂量顺铂对食管癌的治疗价值.方法:100例食管癌患者随机分为2组:顺放组(50例),行超分割放疗配合小剂量顺铂化疗;单放组(50例),行单纯超分割放疗.两组患者均随访5年,观察记录两组患者1、3、5年的生存率、死亡率和毒性反应的发生情况.结果:顺放组1年、3年、5年的生存率均明显高于单放组(P<0.05);两组患者的死因均以局部未控或复发为主,但顺放组局部未控和远处转移的死亡率均明显低于单放组(P<0.05);两组均无严重毒副作用发生.结论:超分割放疗配合小剂量顺铂化疗治疗食管癌疗效较好,值得临床进一步研究推广.

关 键 词:食管肿瘤  超分割放疗  顾铂

SMALL DOSE CISPLATIN COMBINED RADIOTHERAPY FOR TREATMENT OF 50 ESOPHAGEAL CANCERPATIENTS
CHEN Wei,LIU Wen-qiang,SONG Guang-hui.SMALL DOSE CISPLATIN COMBINED RADIOTHERAPY FOR TREATMENT OF 50 ESOPHAGEAL CANCERPATIENTS[J].Journal of Chengde Medical College,2009,26(1).
Authors:CHEN Wei  LIU Wen-qiang  SONG Guang-hui
Institution:CHEN Wei,LIU Wen-qiang,SONG Guang-hui (Taihe Traditional Chinese Medical Hospital,Anhui Taihe 236607,China)
Abstract:Objective:To investigate the therapeutic value of hyperfractionation combined low dose Cisplatin for treatment of esophageal cancer.Methods:100 esophageal cancer patients were randomly divided into 2 groups:H+C group(50 cases),the patients were exerted hyperfractionation combined low dose Cisplatin;C group(50 cases),the patients were simply exerted hyperfractionation.All the patients were followed up for 5 years.The survival rate of patient 1-year,3-year and 5-year after treatment were recorded;the death ra...
Keywords:Esophageal cancer  Hyperfractionation  Cisplatin  
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号